Column GROUP III Gp, L.P. is 10% Owner at Tenaya Therapeutics, Inc. (TNYA). They have made 13 open-market trades across 4 companies since 2019, most recently 2026-02-25.
CIK 0001790965
10 open-market purchases totalling $11.4M since 2019, against 3 sales. Across 10 scored buys the stock is up 33.3% at ninety days, and 27.0 points ahead of the S&P over the same stretch.
10 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| RVMD | 7,977,384 | $1.4B |
| CNST | 2,584,957 | $87.9M |
| SRZN | 1,016,658 | $23.8M |
| TNYA | 1,862,545 | $692K |
| NGM | 445,444 | $686K |
| Total | $1.5B |
Shares reported on the most recent Form 4, priced at the 2026-02-26 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 50% | 60% | 90% |
| Avg Move | -1.6% | +5.1% | +33.3% |
| Alpha | -0.3% | +5.4% | +27.0% |
| Scored | 10 | 10 | 10 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TNYA | SELL | 2026-02-24 | 2026-02-26 | $0.57 | $2.4M | +47.0% | +2.2% | +31.3% |
| TNYA | SELL | 2026-02-20 | 2026-02-24 | $0.61 | $505K | +43.2% | +13.6% | +26.4% |
| TNYA | SELL | 2026-02-10 | 2026-02-12 | $0.69 | $3.0M | -12.8% | +23.8% | +39.7% |
| SRZN | BUY | 2026-01-06 | 2026-01-08 | $19.89 | $300K | -2.8% | +12.2% | +31.4% |
| SRZN | BUY | 2025-12-04 | 2025-12-08 | $19.22 | $695K | +0.9% | -6.2% | +28.6% |
| SRZN | BUY | 2025-11-13 | 2025-11-17 | $12.65 | $4.0M | +27.3% | +60.1% | +88.4% |
| SRZN | BUY | 2024-04-04 | 2024-04-08 | $15.50 | $3.0M | -19.5% | -12.0% | -9.5% |
| TNYA | BUY | 2023-01-19 | 2023-01-23 | $2.50 | $174K | +10.6% | +7.2% | +98.3% |
| TNYA | BUY | 2023-01-17 | 2023-01-19 | $2.51 | $465K | +20.6% | +12.5% | +26.5% |
| CNST | BUY | 2020-03-19 | 2020-03-23 | $22.48 | $937K | +0.8% | +16.4% | +6.9% |
| NGM | BUY | 2020-03-02 | 2020-03-04 | $17.97 | $1.1M | -34.7% | -31.6% | +11.9% |
| NGM | BUY | 2020-02-27 | 2020-02-28 | $17.91 | $607K | -17.5% | -29.0% | +9.7% |
| NGM | BUY | 2019-10-22 | 2019-10-24 | $11.93 | $52K | -1.5% | +21.7% | +40.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.